Skip to main content
Premium Trial:

Request an Annual Quote

DNA Sciences Renames Its Subsidiary Lab to Enhance Vertical Integration

NEW YORK, June 18 - DNA Sciences has changed the name of its wholly-owned subsidiary PPGx laboratories to DNA Sciences Laboratories in an effort to create vertical integration, the company said Monday. 

The lab's products and services will continue to be marketed exclusively through the laboratory. The Morrisville, NC-headquartered lab also has locations in La Jolla, Calif., Cambridge, Mass., and Cambridge, UK. The labs conduct clinical genotyping, assay development and validation, target validation, allele frequency determination, and polymorphism discovery.

"Our goal is to cultivate a unified identity for DNA Sciences across the spectrum of our business activities, including clinical support services and research collaborations that seek to identify genetic variants involved in treatment response," Hugh Rienhoff, CEO of DNA Sciences, said in a statement. "In addition, DNA Sciences Laboratories enables commercialization of products resulting from our own discovery efforts. As genetics becomes integrated into the drug discovery and development process, we anticipate our clinical laboratories business to grow aggressively." 

DNA Sciences studies the role genes play in diseases such as cancer, asthma, and diabetes. It is also planning to commercialize diagnostic tests.  
The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.